Format

Send to

Choose Destination
See comment in PubMed Commons below
J Urol. 1998 May;159(5):1431-6.

An analysis of watchful waiting for clinically localized prostate cancer.

Author information

1
Section of Urology, Pritzker School of Medicine, University of Chicago Medical Center, Illinois, USA.

Abstract

PURPOSE:

We reviewed recent series of watchful waiting for prostate cancer to place this management strategy in appropriate perspective

MATERIALS AND METHODS:

We reviewed the literature and analyzed the 9 articles on watchful waiting published in leading medical journals in the last decade.

RESULTS:

Watchful waiting is probably the best treatment option for men with well and perhaps moderately differentiated, low volume prostate cancer who have a life expectancy of less than 10 years. However, the conclusions derived from watchful waiting studies of older men cannot and should not be applied to younger, healthier men or to those with more advanced or aggressive disease. If treated ineffectively, many of these men will die of prostate cancer.

CONCLUSIONS:

Most men with prostate cancer who have a life expectancy greater than 10 to 15 years should be treated with curative intent.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center